Apogee Therapeutics
$89.50
24
+$6.78+8.2% Today
Statistics
Day High
87.7
Day Low
82.72
52W High
92.2
52W Low
34.65
Volume
306,855
Avg. Volume
-
Mkt Cap
6.22B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
17AugExpected
Expected EPS
-1.072366
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-511.69MNet Income
Analyst Ratings
121.00Average Price Target
The highest estimate is 160.00.
From 11 ratings within the last 6 months. This is not an investment recommendation.
From 11 ratings within the last 6 months. This is not an investment recommendation.
Buy 73%
Hold 27%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow APGE. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Apogee Therapeutics, Inc. is a biotechnology firm, operating via its subsidiary, dedicated to advancing biologic treatments for conditions such as atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and a range of other inflammatory and immunological disorders. Its primary focus includes APG777, a subcutaneous (SQ) monoclonal antibody (mAb) engineered for an extended half-life to treat AD, and APG808, a similarly formulated SQ extended half-life mAb targeting COPD. Furthermore, its earlier-stage pipeline features APG990, another SQ extended half-life mAb designed for AD, and APG222, comprising extended half-life subcutaneous antibodies also aimed at AD. Established in 2022, the company maintains its headquarters in Waltham, Massachusetts.
Show more...
CEO
Dr. Michael Thomas Henderson M.D.
Employees
196
Country
United States
ISIN
US03770N1019
Listings
0 Comments
Share your thoughts
FAQ
What is Apogee Therapeutics stock price today?▼
The current price of APGE is $89.50 USD — it has increased by +8.2% in the past 24 hours. Watch Apogee Therapeutics stock price performance more closely on the chart.
What is Apogee Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Apogee Therapeutics stocks are traded under the ticker APGE.
Is Apogee Therapeutics stock price growing?▼
APGE stock has fallen by -1.54% compared to the previous week, the month change is a +5.79% rise, over the last year Apogee Therapeutics has showed a +110.89% increase.
What is Apogee Therapeutics market cap?▼
Today Apogee Therapeutics has the market capitalization of 6.22B
When is the next Apogee Therapeutics earnings date?▼
Apogee Therapeutics is going to release the next earnings report on August 17, 2026.
What were Apogee Therapeutics earnings last quarter?▼
APGE earnings for the last quarter are -1.06 USD per share, whereas the estimation was -1.07 USD resulting in a +0.59% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Apogee Therapeutics revenue for the last year?▼
Apogee Therapeutics revenue for the last year amounts to 0 USD.
What is Apogee Therapeutics net income for the last year?▼
APGE net income for the last year is -511.69M USD.
How many employees does Apogee Therapeutics have?▼
As of June 11, 2026, the company has 196 employees.
In which sector is Apogee Therapeutics located?▼
Apogee Therapeutics operates in the Health & Wellness sector.
When did Apogee Therapeutics complete a stock split?▼
The last stock split for Apogee Therapeutics was on January 08, 2008 with a ratio of 1:50.
Where is Apogee Therapeutics headquartered?▼
Apogee Therapeutics is headquartered in Waltham, United States.